Are there basic medicines to make patients pour into the large hospital in the community?
Are there basic medicines to make patients pour into the large hospital in the community?
Staff reporter Wang SuPing Medical reform scheme ( Draft) After announcing, reflect fast, have jointly signed and overhauled the suggestion of the medical reform scheme on behalf of many employer's organizations of domestic enterprises, and go and pass to the coordination team of the medical reform. How does the pharmaceutical factory of the foreign capitals think about the medical reform scheme of our country? A few days ago, developed and developed the trade committee (RDPAC) on behalf of medicines of Chinese association of foreign-investment enterprise of the pharmacy enterprises of 38 foreign capitals Executive president desolate to spurt outstanding expressing opinioning of them by Vice President of government affairs the intersection of Huang Ju and brightness. Community basic medicine can meet patient's needs desolate to spurt outstanding to say China propose, set up the intersection of the whole people and medical treatment, ensure, improve the intersection of health care and construction of system, there are the reforms of basic medicine system, medicine price,etc., the direction is very correct. Especially set up basic medicine system, this is that everybody hopes to see most. But say in the scheme, the community health Center in the city (station) , medical health organs of basic unit such as the health clinics in towns and townships, village clinic,etc. should all use the basic medicine, other kinds medical organization want the basic medicine as the first-selected medicine and confirm the using proportion too. If require the community health organ 100% to use the basic medicine, we do not feel very realistic. Some patients hope to get very good service, will impel them only to the large hospital in this way, because the large hospital can offer the medicine various in style, including basic medicine and non- basic medicine. Would not deviate from the original intention that the medical reform shunt the patient so? Want dynamic and environment let the intersection of medicine and enterprise make, research and develop desolate to spurt outstanding to think in basic concept of medicine, is not basically equal to cheap, does not mean economy cheap, only if the basic medicine might not be expensive either. Quality and validity of the improvement medicine are patient's basic guarantee with safe administration. Medicines are different from other goods, can't compromise in quality, the basic medicine is like this too. If market mechanism contribute, medicine have reasonable price, have equilibrium on basic medicine encourage innovations in accessibility. The present medical demand of settlement of accessibility, innovating is for treating those diseases that still can't be cured better. So there must be a motive force and environment, let the pharmacist research and develop. But it's a pity that has lacked this concept of intellectual property protection in the medical reform scheme. The scheme refers to innovation, but not discussed intellectual property protection, then the result will let innovative enterprises go to the other places to make the investment. Influence the accessibility of the medicine or not if costly? Desolate spurts outstandingly and says, there are a lot of factors influencing medicine accessibility, the price is only one of them. The second is the range ensuring being supplied, how many people can get this medicine. The third is the submitting an expense account of medical insurance, how many proportions checked by the government. The foreign enterprise " exceeds national treatment " There is grinding medicines originally and implementing the single pricing policy to foreign pharmacy enterprises of national development and reform committee of historical background, this policy is condemned in order to let the overseas-funded enterprise enjoy by the pharmacy enterprises of China " Exceed national treatment " . It is spurted outstandingly to this view of explaining him that desolate. He thinks, this system has historical background that it exists, it is for attracting the investment taking researching and developing as foundation. However, we must see, the so-called grinding medicines originally and taking the share of the market of Chinese prescribed medicine is very low, only 10%. If someone think grind price of medicine, lower, come down, can relieve the intersection of China and total medical the intersection of expenses and issue of increasing originally, it is not biased. RDPAC has asked the third party of neutrality to investigate, have compared the price grinding medicine originally of China with other 16 markets too, the conclusion drawn is, the price that China grinds medicines originally and is dispatched from the factory is 50% of the developed country, it is 70% of the emerging nation of Asia. Develop the output that is the huge investment in research and development originally, it needs more than 1 billion dollars to research and develop a new compound, time consuming from 10 to 15,it is such in input medicines imitation can't than. Moreover, the production standard of grinding medicines and modelling medicine originally is different, grind the standard that medicines are in accordance with cGMP originally, it is higher than to model the medicine standard. So have rationality that continues existing to price to grind medicines originally alone. To implementing medicines zero price differential, and the intersection of Huang Ju and brightness think medicines addition 15% really too high. Huang JuHui says, considering from a long-term should implement a price differential. But medicines income take hospital to be income proportion very large at present, reduce, raise the price rate will influence income of hospital. The proportion that more realistic choice reduces and raises the price progressively, provided that that increases the input of the hospital, it is medicine that is separated finally, realize medicines zero raises the price. Desolate spurts outstandingly and says, China is one of the several countries of collection standard value-added tax of enterprise few pairs of pharmacy, the average value-added tax rate of medicines that most countries impose is 5%. Expensive and 17% of the value-added tax rate of the links of circulating, has raised the retail price of medicines. So, cancel or reduce the value-added tax rate of Chinese medicines, and carry on the rational reform to the field of circulation, it is very necessary.
|
No comments:
Post a Comment